Towards One Practice for all
Quality control is the basic step in pathology practice in order to ensure accurate patient diagnosis. With the widespread availability of targeted therapeutic options for various cancers, prognostic and therapeutic biomarkers have gained the forefront in guiding patient treatment and outcome. For maximum patient benefit all test results should be reproducible. This requires a consensus form of testing and reporting across all the pathology laboratories. With this vision in mind, we have started External Quality Assurance Scheme (EQAS) for histopathology under the realm of National Cancer Grid.
The National Cancer Grid (NCG) was formed in August 2012 with the mandate of linking cancer centres across India. The initiative, which originally had 14 cancer centres, has rapidly grown now to include 137 major cancer centres, research institutes, patient groups and philanthropic organizations across the country and is amongst the largest cancer networks in the globe. Funded by the Government of India through the Department of Atomic Energy, the NCG has the primary mandate of working towards uniform standards of care across India by adopting evidence-based management guidelines, which are implementable across these centres.
The primary aim of the NCG EQAS is to establish guidelines and protocols for histopathology reporting of that are implementable across the country irrespective of economics.
Ours is a nonprofit scientific organization without economic or political interests. All the protocols provided are as per the standardization carried out at our laboratory. This program is presently being run by and in the Tata Memorial Hospital.